跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 59,818 条关于
“dipeptidyl peptidase-1”
全部
59,818
临床试验
35,513
药物
7,727
机构
1,385
资讯
15,193
去年
Insmed's Brensocatib NDA Accepted by FDA with Priority Review; Anticipated Launch in Q3 2025
2年前
Advancements in Neuroplastogens, KRAS G12C Inhibitors, and Other Therapies Highlighted by Recent Deals and Clinical Readouts
去年
FDA Grants Priority Review to Brensocatib for Non-Cystic Fibrosis Bronchiectasis Treatment
6个月前
UK MHRA Approves First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis
去年
Fosun Pharma Secures $645 Million Global Licensing Deal for Novel DPP-1 Inhibitor XH-S004
去年
Brensocatib Shows Consistent Efficacy in Bronchiectasis Subgroups: Phase 3 ASPEN Data
26天前
Japan Approves BRINSUPRI (brensocatib) as First-in-Class Treatment for Non-Cystic Fibrosis Bronchiectasis
上个月
Expedition Therapeutics Raises $115M Series B to Advance First Global Phase 2 Trial of DPP1 Inhibitor in COPD
去年
Insmed Reports Strong Q2 2025 Results with ARIKAYCE Growth and Brensocatib Approval Pending
2个月前
EMBARC and Insmed Announce Landmark 3,000-Patient Study to Evaluate Whether Brensocatib Can Modify the Course of Bronchiectasis
第 1 页,共 1520 页
上一页
下一页